News

FDA Warns of Heart Failure Risk With Two Diabetes Drugs

11.04.20162772

The US Food and Drug Administration (FDA) has issued a new alert about the potential for increased risk for heart failure in patients taking the type 2 diabetes drugs saxagliptin (Onglyza, AstraZeneca Pharmaceuticals LP) and alogliptin (Nesina, Takeda Pharmaceuticals).

Benefits and Harms of Oral Anticoagulation in Patients With Atrial Fibrillation and Prior Intracranial Hemorrhage

08.04.20162437

What are the risks and benefits in atrial fibrillation (AF) patients with previous intracranial hemorrhage (ICH) treated with warfarin, compared to antiplatelet or no antithrombotic therapies?

Prolonged Dual Antiplatelet Therapy and Diabetes

07.04.20162690

What is the safety and efficacy of prolonged dual antiplatelet therapy (DAPT) in patients with diabetes?

Programme of the educational forum "Russian Cardiovascular Days" 2016 is available to download

06.04.20162837

Global Educational Forum “Russian Cardiovascular Days” 2016 21-23 April, Saint-Petersburg.

Postdischarge Follow-up After AMI and Medication Adherence

06.04.20162799

Is earlier outpatient follow-up after acute myocardial infarction (AMI) associated with higher rates of medication adherence?

Rate, rhythm control strategies both effective in treating postoperative AF

05.04.20162619

Both rate and rhythm control strategies are safe and effective for patients in atrial fibrillation after cardiac surgery, according to data presented at the American College of Cardiology Scientific Session.

Elevated Triglyceride Level Associated With Increased All-Cause Mortality in Established CHD

04.04.20162248

Is there an association between elevated triglycerides and long-term all-cause mortality among patients with established coronary heart disease (CHD)?